Timothy M. Johnson

Timothy M. Johnson

Auto-generated profile, based on publicly available information

Timothy M. Johnson

Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CWChristal A. Worthen
Christal A. Worthen
YCYilei Cui
Yilei Cui
JOJeffrey S. Orringer
Jeffrey S. Orringer
TJTimothy M. Johnson
Timothy M. Johnson
JVJohn J. Voorhees
John J. Voorhees
GFGary Fisher
Gary Fisher

19 December 2019 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
MCMay P. Chan
May P. Chan
KPKomal R. Plouffe
Komal R. Plouffe
CLChia-Jen Liu
Chia-Jen Liu
NPNallasivam Palanisamy
Nallasivam Palanisamy
SCShannon Carskadon
Shannon Carskadon
PHPaul Harms
Paul Harms

1 August 2006 in Journal of the National Comprehensive Cancer Network
Verified
Journal Article
Closed access
SMStanley J Miller
Stanley J Miller
MAMurad Alam
Murad Alam
JAJames Andersen
James Andersen
DBDaniel Berg
Daniel Berg
CBChristopher K Bichakjian
Christopher K Bichakjian
NNNational Comprehensive Cancer Network
National Comprehensive Cancer Network
Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64%. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies. For the most recent version of the guidelines, please visit NCCN.org

1 September 2011 in Dermatologic Surgery
Verified
Journal Article
Open access
MLMathew W. Ludgate
Mathew W. Ludgate
MSMichael S. Sabel
Michael S. Sabel
DFDouglas R. Fullen
Douglas R. Fullen
MFMarcus L. Frohm
Marcus L. Frohm
JLJulia S. Lee
Julia S. Lee
CBChristopher K. Bichakjian
Christopher K. Bichakjian
To evaluate perceived anxiety levels and overall satisfaction after searching the Internet of people with skin cancer. METHODS & MATERIALS We conducted a survey study and prospectively collected data from people newly diagnosed with melanoma or NMSC. RESULTS Four hundred fifteen participants with melanoma and 400 with NMSC completed the questionnaire. Internet use and overall satisfaction with the Internet search increased more than 50% in participants with melanoma from 2005. One-third of participants with melanoma, but many fewer participants with NMSC, reported higher anxiety after Internet use. Participants who were younger, female, more highly educated, and diagnosed with melanoma were most likely to use the Internet to search for information about their diagnosis. CONCLUSION Internet use is prevalent and increasing sharply in individuals with skin cancer. The majority of individuals describe their use of the Internet as a positive experience. Greater anxiety from searching the Internet is more common in individuals with melanoma than in those with NMSC. The authors have indicated no significant interest with commercial supporters....

1 August 2013 in Translational Oncology
Verified
Journal Article
Open access
RMRohit Mehra
Rohit Mehra
SDSaravana M. Dhanasekaran
Saravana M. Dhanasekaran
NPNallasivam Palanisamy
Nallasivam Palanisamy
PVPankaj Vats
Pankaj Vats
XCXuhong Cao
Xuhong Cao
ACArul M. Chinnaiyan
Arul M. Chinnaiyan
E26 transformation-specific (ETS) transcription factors are known to be involved in gene aberrations in various malignancies including prostate cancer; however, their role in melanoma oncogenesis has yet to be fully explored. We have completed a comprehensive fluorescence in situ hybridization (FISH)-based screen for all 27 members of the ETS transcription factor family on two melanoma tissue microarrays, representing 223 melanomas, 10 nevi, and 5 normal skin tissues. None of the melanoma cases demonstrated ETS fusions; however, 6 of 114 (5.3%) melanomas were amplified for ETV1 using a break-apart FISH probe. For the six positive cases, locus-controlled FISH probes revealed that two of six cases were amplified for the ETV1 region, whereas four cases showed copy gains of the entire chromosome 7. The remaining 26 ETS family members showed no chromosomal aberrations by FISH. Quantitative polymerase chain reaction showed an average 3.4-fold (P value = .00218) increased expression of ETV1 in melanomas, including the FISH ETV1-amplified cases, when compared to other malignancies (prostate, breast, and bladder carcinomas). These data suggest that a subset of melanomas overexpresses ETV1 and amplification of ETV1 may be one mechanism for achieving high gene expression.

1 July 1991 in The Journal of Dermatologic Surgery and Oncology
Verified
Journal Article
Open access
PDF file
BNBruce R. Nelson
Bruce R. Nelson
DSD. Bluford Stough
D. Bluford Stough
TJTimothy Johnson
Timothy Johnson
The technique of incisional slit grafting is described and discussed. The results of the use of this technique for hair transplantation in patients with Norwood Type VII or advanced alopecia are reported.